Vtesse, Inc. (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- January 07, 2015
- Vertical
- Pharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $25,000,000
Company Info
- Company Description
- Vtesse, Inc. is a rare disease company dedicated to developing drugs for patients suffering from diseases that are underserved. The first spin-out company from Cydan Development, Inc., Vtesse is working collaboratively with the NIH to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs.
- Market
- Rare diseases
- Location
- Gaithersburg, MD, USA
- Coinvestors
- Alexandria Real Estate Equities, Bay City Capital, Lundbeckfond Ventures, Pfizer Strategic Investments